Trial Profile
To investigate treatment patterns for initial and subsequent therapies in patients with metastatic colorectal cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jun 2017
Price :
$35
*
At a glance
- Drugs Regorafenib (Primary) ; Tipiracil/trifluridine (Primary) ; Bevacizumab; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- 14 Jun 2017 New trial record
- 02 Jun 2017 Results presented at the 53rd Annual Meeting of the American Society of Clinical Oncology.